Scientists have utilised AI to predict T cell receptors, advancing personalised medicine, and boosting immunotherapy and vaccine development.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Stigma within the healthcare system is being tackled head-on with the development of resources to help people with substance dependence access the care they need.
Influenza vaccines are recommended annually, but there’s now an increasing number of different vaccine types. Here’s what to know about this year’s shots.
The TGA has just approved a vaccine against RSV for Australians over 60. Here’s where protection is up to for the youngest children, who are also at risk from the virus.
A review indicates that both cannabinoids and terpenes in cannabis show great promise as antivirals in laboratory research, and could be used to treat infections including COVID-19.
XBB. 1.5 and other subvariants do signal a change in how the virus is mutating. Here’s what this means for Australia and globally.
As children return to school, a new study sheds light on the infection patterns of the various COVID-19 virus variants in open-space learning.
The Omicron strain is driving a rapid increase in China, and is quicker to transmit than other variants.
As the situation evolves, the World Health Organisation expects still more cases of monkeypox will be identified as surveillance expands in non-endemic countries.
A new book based on the world’s largest multi-professional study of its kind relates the distressing experiences of Australian healthcare workers amid the pandemic.
An interdisciplinary “One Health” approach and strong decision-making are our best defences against the next zoonotic-disease outbreak.
2022 will be the year we finally have all the means, measures, and tools to control the pandemic to a non-lethal state.
The new variant of interest, detected in 42 countries, possesses a “constellation of mutations that indicate potential properties of immune escape”.
The next months are going to remain difficult. But I’m still hopeful about the future. There will come a point when enough people are vaccinated that case numbers begin to decrease.
The rapidly-mutating SARS-CoV-2 virus is testing the resilience of the world’s responses, with some variants evolving to become more infectious, and threatening a third wave.
Unless vaccination rates pick up, Victoria’s snap five-day lockdown is unlikely to be enough to get on top of the infectious Delta variant.
The case is growing stronger for COVID-19 vaccine mixing-and-matching, with recent data showing high efficacy and protection against SARS-CoV-2 virus strains.
Scientists are well-advanced in mapping the way forward to develop and repurpose medicines for respiratory virus patients in the post-COVID era.
Using phage therapy to resensitise a type of bacteria to antibiotics, researchers have found a way to revert antibiotic resistance.
When he volunteered to become one of the public faces of Victoria’s COVID-19 health response, Professor Allen Cheng’s life changed course dramatically – and accelerated.
Early analysis suggests Pfizer's COVID-19 vaccine has an efficacy of more than 90%, but more data is still needed.
A behind-the-scenes look at the two vaccine candidates being developed by Monash University and the Doherty Institute.
They're low-cost medicines that can be easily accessed, and are being used to treat seriously ill COVID-19 patients.
Dummy text
